Thyroid Disease in Older Persons

  • Clark T. Sawin
Part of the Contemporary Endocrinology book series (COE, volume 2)


For over 100 yr, physicians have thought that aging and the thyroid gland must somehow be connected; older persons simply looked too much like those with hypothyroidism for their appearance to be coincidental. In 1886 this thinking by analogy led Victor Horsley, then the experimental surgeon for the now-famous Myxoedema Committee, to attribute aging itself to a thyroid defect (1). We now know that this idea is clearly not correct on its face but there is enough truth to it that good medical practice requires that we look closely at older persons for the presence of thyroid disease.


Bone Mineral Density Thyroid Disease Thyroid Nodule Subclinical Hypothyroidism Hypothyroid Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Horsley V. Relation to the thyroid gland to general nutrition. Lancet 1886; 1: 3–5.Google Scholar
  2. 2.
    Mariotti S, Franceschi C, Cossarizza A, Pinchera A. The aging thyroid. Endocr Rev 1995; 16: 686–715.PubMedGoogle Scholar
  3. 3.
    Hurley JR. Thyroid disease in the elderly. Med Clin North Amer 1983; 67: 497–516.Google Scholar
  4. 4.
    Levy EG. Thyroid disease in the elderly. Endocr Clin North Amer 1991; 75: 151–167.Google Scholar
  5. 5.
    Finucane P, Anderson C. Thyroid disease in older patients. Diagnosis and treatment. Drugs and Aging 1995; 6: 268–277.PubMedGoogle Scholar
  6. 6.
    Sawin CT, Chopra D, Azizi F, et al. The aging thyroid. Increased prevalance of elevated serum thyrotropin levels in the elderly. JAMA 1979; 242: 247–250.PubMedGoogle Scholar
  7. 7.
    Poehlman ET, McAuliffe TL, Van Houten DR, Danforth E Jr. Influence of age and endurance training on metabolic rate and hormones in healthy men. Am J. Physiol 1990; 259: E66–72.PubMedGoogle Scholar
  8. 8.
    Gaffney GW, Gregerman RI, Shock NW. Relationship of age to the thyroidal accumulation, renal excretion and distribution of radioiodide in euthyroid man. J Clin Endocrinol Metab 1962; 22: 784–794.PubMedGoogle Scholar
  9. 9.
    Gregerman RI, Gaffney GW, Shock NW, Crowder SE. Thyroxine turnover in euthyroid man with special reference to changes with age. J Clin Invest 1962; 41: 2065–2074.PubMedGoogle Scholar
  10. 10.
    Oddie TH, Meade JH Jr, Fisher DA. An analysis of published data on thyroxine turnover in human subjects. J Clin Endocrinol Metab 1966; 26: 425–436.PubMedGoogle Scholar
  11. 11.
    Herrmann J, Rusche HJ, Kroll HJ, Hilger P, Kruskemper HL. Free triiodothyronine (T3) and thyroxine (T4) serum levels in old age. Horm Metab Res 1974; 6: 239–240.PubMedGoogle Scholar
  12. 12.
    Caplan RH, Wickus G, Glasser JE, Davis K, Wahner HW. Serum concentrations of the iodothyronines in elderly subjects: decreased triiodothyroinine (T3) and free T3 index. J Amer Geriatr Soc 1981; 2: 19–24.Google Scholar
  13. 13.
    Harman SM, Wehmann RE, Blackman MR. Pituitary-thyroid hormone economy in healthy aging men: basal indices of thyroid function and thyrotropin responses to constant infusions of thyrotropin releasing hormone. J Clin Endocrinol Metab 1984; 58: 320–326.PubMedGoogle Scholar
  14. 14.
    Penzes L, Gergely I. Thyroid hormones in the light of general health status of Hungarian centenarians. Age 1989; 12: 137–138.Google Scholar
  15. 15.
    Mariotti S, Barbesino G, Caturegli P, Bartalena L, Sansoni P, Fagnoni F, Monti D, Fagiolo U, Frasceschi C, Pinchera A. Complex alteration of thyroid function in healthy centenarians. J Clin Endocrinol Metab 1993; 77: 1130–1134.PubMedGoogle Scholar
  16. 16.
    Van Coevorden A, Laurent E, Decoster C, Kerkhofs M, Neve P, Van Cauter E, Mockel J. Decreased basal and stimulated thyrotropin secretion in healthy elderly men. J Clin Endocrinol Metab 1989; 69: 177–185.PubMedGoogle Scholar
  17. 17.
    Sawin CT, Castelli WP, Hershman JM, McNamara P, Bacharach P. The aging thyroid. Thyroid deficiency in the Framingham Study. Arch Intern Med 1985; 145: 1386–1388.PubMedGoogle Scholar
  18. 18.
    Doucet J, Trivalle Ch, Chassagne Ph, Perol M-B, Vuillermet P, Manchon N-D, Menard J-F, Bercoff E. Does age play a role in clinical presentation of hypothyroidism? J Amer Geriatr Soc 1994; 42: 984–986.Google Scholar
  19. 19.
    Ooi DS, Mahadevan MS, Greenway DC, Gertler SZ. Evaluation of four commercially available assays for free thyroxin. Clin Chem 1988; 334: 2302–2307.Google Scholar
  20. 20.
    Penney MD, O’Sullivan DJ. Total or free thyroxin as a primary test of thyroid function. Clin Chem 1987; 33: 170–171.PubMedGoogle Scholar
  21. 21.
    Vagenakis AG, Rapoport B, Azizi F, Portnay GI, Braverman LE, Ingbar SH. Hyperresponse to thyrotropin-releasing hormone accompanying small decreases in serum thyroid hormone concentrations. J Clin Invest 1974; 54: 913–918.PubMedGoogle Scholar
  22. 22.
    John R, Henley R, Lloyd G, Elder GH. Evaluation of a new strategy for detection of thyroid dysfunction in the routine laboratory. Clin Chem 1988; 34: 1110–1114.PubMedGoogle Scholar
  23. 23.
    Feldkamp CS, McKenna MJ. Contemporary approach to thyroid disease emphasizing use of high-sensitivity thyrotropin assays. Henry Ford Hosp Med J 1991; 39: 25–29.PubMedGoogle Scholar
  24. 24.
    Surks M, Chopra IJ, Mariash CN, Nicoloff JT, Solomon DH. American Thyroid Association guidelines for the use of laboratory tests in thyroid disorders. JAMA 1990; 263: 1529–1532.Google Scholar
  25. 25.
    Hay ID, Bayer MF, Kaplan MM, Klee GG, Larsen PR, Spencer CA. American Thyroid Association assessment of current free thyroid hormone and thyrotropin measurements and guidelines for future clinical assays. Clin Chem 1991; 37: 2002–2008.PubMedGoogle Scholar
  26. 26.
    Schectman JM, Pawlson LG. The cost-effectiveness of three thyroid function testing strategies for suspicion of hypothyroidism in a primary care setting. J Gen Intern Med 1990; 5: 9–15.PubMedGoogle Scholar
  27. 27.
    Goldstein BJ, Mushlin AI. Use of a single thyroxine test to evaluate ambulatory medical patients for suspected hypothyroidism. J Gen Intern Med 1987; 2: 20–24.PubMedGoogle Scholar
  28. 28.
    Bahemuka M, Hodkinson H M. Screening for hypothyroidism in elderly inpatients. Brit Med J 1975; 1: 601–603.Google Scholar
  29. 29.
    Tunbridge WMG, Evered DC, Hall R, Appleton D, Brewis M, Clark F, Grimley Evans J, Young E, Bird T, Smith PA. The spectrum of thyroid disease in a community: the Whickham Survey. Clin Endocrinol 1977; 7: 481–493.Google Scholar
  30. 30.
    Robuschi G, Safran M, Braverman LE, Gnudi A, Roti E. Hypothyroidism in the elderly. Endocr Rev 1987; 8: 142–153.PubMedGoogle Scholar
  31. 31.
    Vanderpump MPJ, Tunbridge WMG, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Hasan DM, Rodgers H, Tunbridge F, Young ET. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol 1995; 43: 55–68.Google Scholar
  32. 32.
    Sawin CT, Bigos ST, Land S, Bacharach P. The aging thyroid. Relationship between elevated serum thyrotropin level and thyroid antibodies in elderly patients. Amer J Med 1985; 79: 591–595.PubMedGoogle Scholar
  33. 33.
    Whittingham S, Irwin J Mackay IR, Marsh S, Cowling DC. Autoantibodies in healthy subjects. Australas Ann Med 1969; 18: 130–134.Google Scholar
  34. 34.
    Roti E, Gardini E, Minelli R, Bianconi L, Braverman LE. Prevalance of anti-thyroid peroxidase antibodies in serum in the elderly: comparison with other tests for anti-thyroid antibodies. Clin Chem 1992; 38: 88–92.PubMedGoogle Scholar
  35. 35.
    Nilsson G, Nordlander S, Levin K. Studies on subclinical hypothyroidism with special reference to the serum lipid pattern. Acta Med Scand 1976; 200: 63–67.PubMedGoogle Scholar
  36. 36.
    Kung AWC, Pang RWC, Janus ED. Elevated serum lipoprotein(a) in subclinical hypothyroidism. Clin Endocrinol 1995; 43: 445–449.Google Scholar
  37. 37.
    Althaus BU, Staub J-J, Ryff-DeLeche A, Oberhansli A, Stahelin HB. LDL/HDL-changes in subclinical hypothyroidism: possible risk factors for coronary heart disease. Clin Endocrinol 1988; 28: 157–163.Google Scholar
  38. 38.
    Caron Ph, Calazel C, Parra HJ, Hoff M, Louvet JP. Decreased HDL cholesterol in subclinical hypothyroidism: the effect of L-thyroxine therapy. Clin Endocrinol 1990; 33: 519–523.Google Scholar
  39. 39.
    Bansal SK, Sahi SP, Basu SK, Old JM. Hypothyroidism in elderly males-an under diagnosis. Brit J Clin Pract 1986; 40: 17–18.PubMedGoogle Scholar
  40. 40.
    Tieche M, Lupi GA, Gutzwiller F, Grob PJ, Studer H, Burgi H. Borderline low thyroid function and thyroid autoimmunity. Risk factors for coronary heart disease? Brit Heart J 1981; 46: 202–206.PubMedGoogle Scholar
  41. 41.
    Vanderpump MPJ, Tunbridge WMG, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Hasan DM, Rodgers H, Tunbridge F, Young ET. The development of ischaemic heart disease in relation to markers of thyroid failure in a 20-year follow-up of a community. Thyroid 1996 (in press).Google Scholar
  42. 42.
    Asher R. Myxoedematous madness. Brit Med J 1949; 2: 555–562.PubMedGoogle Scholar
  43. 43.
    Osterweil D, Syndulko K, Cohen SN, Pettler-Jennings PD, Hershman JM, Cummings JL, Tourtellotte WW, Solomon DH. Cognitive function in non-demented older adults with hypothyroidism. J Amer Geriatr Soc 1992; 40: 325–335.Google Scholar
  44. 44.
    Monzani F, Del Guerra P, Caraccio N, Pruneti CA, Luisi M, Baschieri L. Subclinical hypothyroidism: neurobehavioral features and beneficial effects of L-thyroxine treatment. Clin Invest 1993; 71: 367–371.Google Scholar
  45. 45.
    Tappy L, Randin JP, Schwed P, Wertheimer J, Lemarchand-Beraud, Th. Prevalence of thyroid disorders in psychogeriatric inpatients. A possible relationship of hypothyroidism with neurotic depression but not with dementia. J Am Geriatr Soc 1987; 35: 526–531.PubMedGoogle Scholar
  46. 46.
    Sweer L, Martin DC, Ladd RA, Miller JK, Karpf M. The medical evaluation of elderly patients with major depression. J Gerontol 1988; 43: M53–58.Google Scholar
  47. 47.
    Arem R, Patsch W. Lipoprotein and apolipoprotein levels in subclinical hypothyroidism. Effect of thyroid therapy. Arch Intern Med 1990; 150: 2097–2100.PubMedGoogle Scholar
  48. 48.
    Bogner U, Arntz H-R, Peters H, Schleusener H. Subclinical hypothyroidism and hyperlipoproteinemia: indiscriminate L-thyroxine treatment not justified. Acta Endocrinol 1993; 128: 202–206.PubMedGoogle Scholar
  49. 49.
    Arem R, Escalante DA, Arem N, Morrisett JD, Patsch W. Effect of L-thyroxine therapy on lipoprotein fractions in overt and subclinical hypothyroidism, with special reference to lipoprotein(a). Metabolism 1995; 44: 1559–1563.PubMedGoogle Scholar
  50. 50.
    Cooper DS, Halpern R, Wood LC, Levin AA, Ridgway EC. L-thyroxine therapy in subclinical hypothyroidism. A double-blind, placebo-controlled trial. Ann Intern Med 1984; 101: 18–24.PubMedGoogle Scholar
  51. 51.
    Nystrom E, Caidahl K, Fager G, Wikkelso C, Lundberg P-A, Lindstedt G. A double-blind cross-over 12-month study of L-thyroxine treatment of women with ‘subclinica’ hypothyroidism. Clin Endocrinol 1988; 29: 63–76.Google Scholar
  52. 52.
    Rahman Q, Haboubi NY, Hudson PR, Lee GS, Shah IU. The effect of thyroxine on small intestinal motility in the elderly. Clin Endocrinol 1991; 35: 443–446.Google Scholar
  53. 53.
    Series JJ, Biggart EM, O’Reilly DStJ, Packard CJ, Shepherd J. Thyroid dysfunction and hypercholesterolaemia in the general population of Glasgow, Scotland. Clin Chim Acta 1988; 172: 217–222.Google Scholar
  54. 54.
    Ball MJ, Griffiths D, Thorogood M. Asymptomatic hypothyroidism and hypercholesterolaemia. J Roy Soc Med 1991; 84: 527–529.PubMedGoogle Scholar
  55. 55.
    Haupt M, Kurz A. Reversibility of dementia in hypothyroidism. J Neurol 1993; 240: 333–335.PubMedGoogle Scholar
  56. 56.
    Clarfield AM. The reversible dementias: do they reverse? Ann Intern Med 1988; 109: 476–486.PubMedGoogle Scholar
  57. 57.
    Smith CL, Granger CV. Hypothyroidism producing reversible dementia. Am J Phys Med Rehabil 1992; 71: 28–30.PubMedGoogle Scholar
  58. 58.
    Toft AD. Thyroxine replacement therapy. Clin Endocrinol 1991; 34: 103–105.Google Scholar
  59. 59.
    Mandel SJ, Brent GA, Larsen PR. Levothyroxine therapy in patients with thyroid disease. Ann Intern Med 1993; 119: 492–502.PubMedGoogle Scholar
  60. 60.
    Toft AD. Thyroxine therapy. N Engl J Med 1994; 331: 174–180.PubMedGoogle Scholar
  61. 61.
    Franklyn J. ‘Subclinical hypothyroidism’ • to treat or not to treat, that is the question. Clin Endocrinol 1995;43:443–444.Google Scholar
  62. 62.
    Rosenbaum RL, Barzel US. Levothyroxine replacement dose for primary hypothyroidism decreases with age. Ann Intern Med 1982; 96: 53–55.PubMedGoogle Scholar
  63. 63.
    Sawin CT, Herman T, Molitch ME, London MH, Kramer SM. Aging and the thyroid. Decreased requirement for thyroid hormone in older hypothyroid patients. Am J Med 1983; 75: 206–209.PubMedGoogle Scholar
  64. 64.
    Sherman SI, Ladenson PW. Percutaneous transluminal coronary angioplasty in hypothyroidism. Am J Med 1991; 90: 367–370.PubMedGoogle Scholar
  65. 65.
    Mantzoros CS, Evangelopoulou K, Moses AC. Outcome of percutaneous transluminal coronary angioplasty in patients with subclinical hypothyroidism. Thyroid 1995; 5: 383–387.PubMedGoogle Scholar
  66. 66.
    Hay ID, Duick DS, Vlietstra RE, Maloney JD, Pluth JR. Thyroxine therapy in hypothyroid patients undergoing coronary revascularization: a retrospective analysis. Ann Intern Med 1981; 95: 456–457.PubMedGoogle Scholar
  67. 67.
    Weinberg AD, Brennan MD, Gorman CA, Marsh HM, O’Fallon WM. Outcome of anesthesia and surgery in hypothyroid patients. Arch Intern Med 1983; 143: 893–897.PubMedGoogle Scholar
  68. 68.
    Sawin CT, Geller A, Hershman JM, Castelli W, Bacharach P. The aging thyroid. The use of thyroid hormone in older persons. JAMA 1989; 261: 2653–2655.PubMedGoogle Scholar
  69. 69.
    Friedman D, Reed RL, Mooradian AD. The prevalence of overmedication with levothyroxine in ambulatory elderly patients. Age 1992; 15: 9–13.Google Scholar
  70. 70.
    Parle JV, Franklyn JA, Cross KW, Jones SR, Sheppard MC Thyroxine prescription in the community: serum thyroid stimulating hormone level assays as an indicator of undertreatment or overtreatment. Brit J Gen Pract 1993; 43: 107–109.Google Scholar
  71. 71.
    Choe W, Hays MT. Absorption of oral thyroxine. The Endocrinologist 1995; 5: 222–228.Google Scholar
  72. 72.
    Arafah BM. Decreased levothyroxine requirement in women with hypothyroidism during androgen therapy for breast cancer. Ann Intern Med 1992; 121: 247–251.Google Scholar
  73. 73.
    Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P, Wilson PWF, Benjamin EJ, D’Agostino RB. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 1994; 331: 1249–1252.PubMedGoogle Scholar
  74. 74.
    Sawin CT. Thyroid dysfunction in older persons. Adv Intern Med 1991; 37: 223–248.Google Scholar
  75. 75.
    Cooper DS. Subclinical hypothyroidism. Adv Endocrinol Metab 1991; 2: 77–88.Google Scholar
  76. 76.
    Sawin CT. Subclinical hypothyroidism in older persons. Clin Geriatr Med 1995; 11: 231–238.PubMedGoogle Scholar
  77. 77.
    Helfand M, Crapo LM. Screening for thyroid disease. Ann Intern Med 1990; 112: 840–849.PubMedGoogle Scholar
  78. 78.
    Danese MD, Powe NR, Sawin CT, Ladenson PW. Screening for mild thyroid failure at the periodic health examination: a decision and cost-effectiveness analysis. JAMA 1996 (in press).Google Scholar
  79. 79.
    Davis PJ, Davis FB. Hyperthyroidism in patients over the age of 60 years. Clinical features in 85 patients. Medicine 1974; 53: 161–181.PubMedGoogle Scholar
  80. 80.
    Nystrom E, Lindstedt G, Lundberg P-A, Lundholm K, Smith U. Recognizing hyperthyroidism in the elderly. Clin Chem 1987; 33: 429–431.PubMedGoogle Scholar
  81. 81.
    Greenwood RM, Daly JG, Himsworth RL. Hyperthyroidism and the impalpable thyroid gland. Clin Endocrinol 1985; 22: 583–587.Google Scholar
  82. 82.
    Tibaldi JM, Barzel US, Albin J, Surks M. Thyrotoxicosis in the very old. Am J Med 1986; 81: 619–622.PubMedGoogle Scholar
  83. 83.
    Nordyke RA, Gilbert FI Jr, Harada ASM. Graves’ disease. Influence of age on clinical findings. Arch Intern Med 1988; 148: 626–631.PubMedGoogle Scholar
  84. 84.
    Thomas FB, Mazzaferri EL, Skillman TG. Apathetic thyrotoxicosis: a distinctive clinical and laboratory entity. Ann Intern Med 1970; 72: 679–685.PubMedGoogle Scholar
  85. 85.
    Borst GC, Eil C, Burman KD. Euthyroid hyperthyroxinemia. Ann Intern Med 1983; 98: 366–378.PubMedGoogle Scholar
  86. 86.
    Burrows AW, Shakespear RA, Hesch RD, Cooper E, Aickin CM, Burke CW. Thyroid hor-mones in the elderly sick: “T4 euthyroidism.” Brit Med J 1975; 4: 437–439.Google Scholar
  87. 87.
    Gavin LA, Rosenthal M, Cavalieri RR. The diagnostic dilemma of isolated hyperthyroxinemia in acute illness. JAMA 1979; 242: 251–253.PubMedGoogle Scholar
  88. 88.
    Livingston EH, Hershman JM, Sawin CT, Yoshikawa TT. Prevalance of thyroid disease and abnormal thyroid tests in older hospitalized and ambulatory persons. J Am Geriatr Soc 1987; 35: 109–114.PubMedGoogle Scholar
  89. 89.
    Kaplan MM, Utiger RD. Diagnosis of hyperthyroidism. Clin Endocrinol Metab 1978; 7: 97–113.PubMedGoogle Scholar
  90. 90.
    Ross DS, Ardisson LJ, Meskell MJ. Measurement of thyrotropin in clinical and subclinical hyperthyroidism using a new chemiluminescent assay. J Clin Endocrinol Metab 1989; 69: 684–688.PubMedGoogle Scholar
  91. 91.
    Eggertsen R, Petersen K, Lundberg P-A, Nystrom E, Lindstedt G. Screening for thyroid disease in a primary care unit with a thyroid stimulating hormone assay with a low detection limit. Brit Med J 1988; 297: 1586–1592.PubMedGoogle Scholar
  92. 92.
    Petersen K, Lindstedt G, Lundberg P-A, Bengtsson C, Lapidus L, Nystrom E. Thyroid disease in middle-aged and elderly Swedish women: thyroid-related hormones, thyroid dysfunction and goitre in relation to age and smoking. L Intern Med 1991; 229: 407–414.Google Scholar
  93. 93.
    Sawin CT, Geller A, Kaplan MM, Bacharach P, Wilson PWF, Hershman JM. Low serum thyrotropin (thyroid-stimulating hormone) in older persons without hyperthyroidism. Arch Intern Med 1991; 151: 165–168.PubMedGoogle Scholar
  94. 94.
    Ronnov-Jessen V, Kirkegaard C. Hyperthyroidism-a disease of old age? Brit Med J 1973; 1: 41–43.PubMedGoogle Scholar
  95. 95.
    Sundbeck G, Lundberg P-A, Lindstedt G, Jagenburg R, Eden S. Incidence and prevalence of thyroid disease in elderly women: results from the longitudinal population study of elderly people in Gothenburg, Sweden. Age and Ageing 1991; 20: 291–298.PubMedGoogle Scholar
  96. 96.
    Laurberg P, Pedersen KM, Vestergaard H, Sigurdsson G. High incidence of multinodular toxic goiter in the elderly population in a low iodine intake area vs. high incidence of Graves’ disease in the young in a high iodine intake area: comparative surveys of thyrotoxicosis epidemiology in East-Jutland Denmark and Iceland. J Intern Med 1991; 229: 415–420.PubMedGoogle Scholar
  97. 97.
    Lundgren E, Christensen SB. Decreasing incidence of thyrotoxicosis in an endemic goiter inland area of Sweden. Clin Endocrinol 1990; 33: 133–138.Google Scholar
  98. 98.
    Baltisberger BL, Minder CE, Burgi H. Decrease of incidence of toxic nodular goiter in a region of Switzerland after full correction of mild iodine deficiency. Eur J Endocrinol 1995; 132: 546–549.PubMedGoogle Scholar
  99. 99.
    Gordon M, Gryfe CI. Hyperthyroidism with painless subacute thyroiditis in the elderly. JAMA 1981; 246: 2354–2355.PubMedGoogle Scholar
  100. 100.
    Barclay ML, Brownlie BEW, Turner JG, Wells JE. Lithium associated thyrotoxicosis: a report of 14 cases, with statistical analysis of incidence. Clin Endocrinol 1994; 40: 759–764.Google Scholar
  101. 101.
    Cooper DS. Tobacco and Graves’ disease. Smoking gun or smoke and mirrors? JAMA 1993; 269: 518–519.Google Scholar
  102. 102.
    Stott DJ, McLellan AR, Finlayson J, Chu P, Alexander WD. Elderly patients with suppressed serum TSH but normal free thyroid hormone levels usually have mild thyroid overactivity and are at increased risk of developing overt hyperthyroidism. Quart J Med 1991; 78: 77–84.PubMedGoogle Scholar
  103. 103.
    Ross DS. Subclinical thyrotoxicosis. In: Braverman LE, Utiger RD, eds. The Thyroid. 7th ed. Lippincott-Raven, Philadelphia, 1996, pp. 1016–1020.Google Scholar
  104. 104.
    Sundbeck G, Jagenburg R, Johansson P-M, Eden S, Lindstedt G. Clinical significance of low serum thyrotropin concentration by chemiluminometric assay in 85-year-old women and men. Arch Intern Med 1991; 151: 549–556.PubMedGoogle Scholar
  105. 105.
    Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley J, Black D, Vogt TM, et al. Risk factors for hip fracture in white women. New Eng J Med 1995; 332: 767–773.PubMedGoogle Scholar
  106. 106.
    Wejda B, Hintze G, Katschinski B, Olbricht Th, Benker G. Hip fractures and the thyroid: a case-control study. J Intern Med 1995; 237: 241–247.PubMedGoogle Scholar
  107. 107.
    Solomon BL, Wartofsky L, Burman KD. Prevalence of fractures in postmenopausal women with thyroid disease. Thyroid 1993; 3: 17–23.PubMedGoogle Scholar
  108. 108.
    Duncan WE, Chang A, Solomon B, Wartofsky L. Influence of clinical characteristics and parameters associated with thyroid hormone therapy on the bone mineral density of women treated with thyroid hormone. Thyroid 1994; 4: 183–190.PubMedGoogle Scholar
  109. 109.
    Franklyn J, Betteridge J, Holder R, Daykin J, Lilley J, Sheppard M. Bone mineral density in thyrozine treated females with or without a previous history of thyrotoxicosis. Clin Endocrinol 1994; 41: 425–432.Google Scholar
  110. 110.
    Grant DJ, McMurdo MET, Mole PA, Paterson CR. Is previous hyperthyroidism still a risk factor for osteoporosis in post-menopausal women? Clin Endocrinol 1995; 43: 339–345.Google Scholar
  111. 111.
    Diamond T, Nery L, Hales I. A therapeutic dilemma: a suppressive doses of thyroxine significantly reduce bone mineral measurements in both premenopausal and postmenopausal women with thyroid carcinoma. J Clin Endocrinol Metab 1990; 72: 1184–1188.Google Scholar
  112. 112.
    Lehmke J, Bogner U, Felsenberg D, Peters H, Schleusener H. Determination of bone mineral density by quantitative computed tomography and single photon absorptiometry in subclinical hyperthyroidism: a risk of early osteopaenia in post-menopausal women. Clin Endocrinol 1992; 36: 511–517.Google Scholar
  113. 113.
    Kung AWC, Lorentz T, Tam SCF. Thyroxine suppressive therapy decreases bone mineral density in post-menopausal women. Clin Endocrinol 1993; 39: 535–540.Google Scholar
  114. 114.
    Faber J, Galloe AM. Changes in bone mass during prolonged subclinical hyperthroidism due to L-thyroxine treatment: a meta-analysis. Eur J Endocrinol 1994; 130: 350–356.PubMedGoogle Scholar
  115. 115.
    Grant DJ. McMurdo MET, Mole PA, Paterson CR, Davies RR. Suppressed TSH levels secondary to thyroxine replacement therapy are not associated with osteroporosis. Clin Endocrinol 1993; 39: 529–533.Google Scholar
  116. 116.
    Fujiyama K, Kiriyama T, Ito M, Kimura H, Ashizawa K, Tsuruta M, Nagayama Y, Villadolid MC, Yokoyama N, Nagataki S. Suppressive doses of thyroxine do not accelerate age-related bond loss in late postmenopausal women. Thyroid 1995; 5: 13–17.PubMedGoogle Scholar
  117. 117.
    Schneider DL, Barrett-Connor EL, Morton DJ. Thyroid hormone use and bone mineral density in elderly women. JAMA 1994; 271: 1245–1249.PubMedGoogle Scholar
  118. 118.
    Franklyn JA, Betteridge J, Holder R, Sheppard MC. Effect of estrogen replacement therapy upon bone mineral density in thyroxine-treated postmenopausal women with a past history of thyrotoxicosis. Thyroid 1995; 5: 359–363.PubMedGoogle Scholar
  119. 119.
    Hawkins F, Rigopoulou D, Papapietro K, Lopez MB. Spinal bone mass after long-term treatment with L-thyroxine in postmenopausal women with thyroid cancer and chronic lymphocytic thyroiditis. Calcif Tissue Int 1994; 54: 16–19.PubMedGoogle Scholar
  120. 120.
    Schnedier DL, Barrett-Connor EL, Morton DJ. Thyroid hormone use and bone mineral density in elderly men. Arch Intern Med 1995; 155: 2005–2007.Google Scholar
  121. 121.
    Foldes J, Tarjan G, Szathmari M, Varga F, Krasznai I, Horvath CS. Bone mineral density in patients with endogenous subclinical hyperthyroidism: is this thyroid status a risk factor for osteoporosis? Clin Endocrinol 1993; 39: 521–527.Google Scholar
  122. 122.
    Mudde AH, Reijnders FJL, Nieuwenhuijzen Kruseman AC. Peripheral bone density in women with untreated multinodular goitre. Clin Endocrinol 1992; 37: 35–39.Google Scholar
  123. 123.
    Wartofsky L, Glinoer D, Solomon B, Nagatski S, Lagasse R, Nagayama Y, Izumi M. Differences and similarities in the diagnosis and treatment of Graves’disease in Europe, Japan, and the United States. Thyroid 1191; 1: 129–135.Google Scholar
  124. 124.
    Braverman LE, Roti E. The role of iodine in the management of Graves’ disease. Endocr Pract 1995; 1: 200–204.PubMedGoogle Scholar
  125. 125.
    Mudde AH, Houben AJHM, Nieuwenhuijzen Kruseman AC. Bone metabolism during anti-thyroid drug treatment of endogenous subclinical hyperthyroidism. Clin Endocrinol 1994; 41: 421–424.Google Scholar
  126. 126.
    Browning MCK, Ford RP, Callaghan SJ, Fraser CG. Intra-and interindividual biological variation of five analytes used in assessing thyroid function: implications for necessary standards of performance and the interpretation of results. Clin Chem 1986; 32: 962–966.PubMedGoogle Scholar
  127. 127.
    Hall P, Lundell G, Holm L-E. Mortality in patients treated for hyperthyroidism with iodine-131. Acta Endocrinol 1993; 128: 230–234.PubMedGoogle Scholar
  128. 128.
    Hegedus L, Perrild H, Poulsen LR, Andersen JR, Holm B, Schnohr P, Jensen G, Hansen JM. The determination of thyroid volume by ultrasound and its relationship to body weight, age, and sex in normal subjects. J Clin Endocrinol Metab 1983; 56: 260–263.PubMedGoogle Scholar
  129. 129.
    Berghout A, Wiersinga WM, Smits NJ, Touber JL. Interrelationships between age, thyroid volume, thyroid nodularity, and thyroid function in patients with sporadic nontoxic goiter. Am J Med 1990; 89: 602–608.PubMedGoogle Scholar
  130. 130.
    Nygaard B, Gideon P, Dige-Petersen H, Jespersen N, Solling K, Veje A. Thyroid voluem and morphology and urinary iodine excretion in a Danish municipality. Acta Endocrinol 1993; 129: 505–510.PubMedGoogle Scholar
  131. 131.
    Gonczi J, Szabolcs I, Kovacs Z, Kakosy T, Goth M, Szilagyi G. Ultrasonography of the thyroid gland in hospitalized, chronically ill geriatric patients: thyroid volume, its relationship to age and disease, and the prevalence of diffuse and nodular goiter. J Clin Ultrasound 1994; 22: 257–261.PubMedGoogle Scholar
  132. 132.
    Vander JB, Gaston EA, Dawber TR. The significance of nontoxic thyroid nodules. Final report of a 15-year study of the incidence of thyroid maligancy. Ann Intern Med 1968; 69: 537–540.PubMedGoogle Scholar
  133. 133.
    Collins JG. Prevalence of selected chronic conditions, United States, 1983–85. National Center for Health Statistics. Advance Data From Vital and Health Statistics. No. 155. DHHS Pub. No. (PHS) 88–1250. Public Health Service. Hyattsville, MD, p. 12.Google Scholar
  134. 134.
    Mortensen JD, Woolner LB, Bennett WA. Gross and microscopic findings in clinically normal thyroid glands. J Clin Endocrinol 1955; 15: 1270–1280.Google Scholar
  135. 135.
    Ezzat S, Sarti DA, Cain DR, Braunstin GD. Thyroid incidentalomas. Prevalence by palpation and ultrasonography. Arch Intern Med 1994; 154: 1838–1840.PubMedGoogle Scholar
  136. 136.
    Brander A, Viikinkoski P, Tuuhea J, Voutilainen L, Kivisaari L. Clinical versus ultrasound examination of the thyroid gland in common clinical practice. J Clin Ultrasound 1992; 20: 37–42.PubMedGoogle Scholar
  137. 137.
    Witterick IJ, Abel SM, Hartwick W, Mullen B, Salem S. Incidence and types of nonpalpable thyroid nodules in thyroids removed for palpable disease. J Otolaryngol 1993; 22: 294–300.PubMedGoogle Scholar
  138. 138.
    Tan GH, Gharib H, Reading CC. Solitary thyroid nodule. Comparison between palpation and ultrasonography. Arch Intern Med 1995; 155: 2418–2423.PubMedGoogle Scholar
  139. 139.
    Nygaard B, Hegedus L, Gervil M, Hjalgrim H, Soe-Hensen P, Hensen JM. Radioiodine treatment of multinodular non-toxic goitire. Brit Med J 1993; 307: 828–832.PubMedGoogle Scholar
  140. 140.
    Huysmans DAKC, Hermus ARMM, Corstens FHM, Barentsz, JO, Kloppenborg PWC. Large, compressive goiters treated with radioiodine. Ann Intern Med 1994; 121: 757–762.PubMedGoogle Scholar
  141. 141.
    Wesche MF, Tiel-v-Buul MM, Smits NJ, Wiersinga WM. Reduction in size by 131-I therapy in patients with non-toxic multinodular goiter. Eur J. Endocrinol 1995; 132: 86–87.PubMedGoogle Scholar
  142. 142.
    Nygaard B, Faber J, Hegedus L. Acute changes in thyroid volume and function following 131-I therapy of multinodular goitre. Clin Endocrinol 1994; 41: 715–718.Google Scholar
  143. 143.
    Belfiore A, LaRosa GL, LaPorta GA, Giuffrida D, Milazzo G, Lupo L, Regalbuto C, Vigneri R. Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity. Am J Med 1992; 93: 363–369.PubMedGoogle Scholar
  144. 144.
    Akslen LA, Haldorsen T, Thoresen SO, Glattre E. Survival and causes of death in thyroid cancer: a population-based study of 2479 cases from Norway. Canc Res 1991; 51: 1234–1241.Google Scholar
  145. 145.
    Casara D, Rubello D, Saladini G, DeBesi P, Fassina A, Busnardo B. Differentiated thyroid carcinoma in the elderly. Aging Clin Exp Res 1992; 4: 333–339.Google Scholar
  146. 146.
    Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993; 114: 1050–1058.PubMedGoogle Scholar
  147. 147.
    Bhakri HL, Fisher R, Khadri A, MacMahon DG. Longitudinal study of thyroid function in acutely ill elderly patients using a sensitive TSH assay-defer testing until recovery. Gerontology 1990; 36: 140–144.PubMedGoogle Scholar
  148. 148.
    Carter JN, Eastman CJ, Corcoran JM, Lazarus L. Effect of severe, chronic illness on thyroid function. Lancet 1974; 2: 971–974.PubMedGoogle Scholar
  149. 149.
    Docter R, van Toor H, Krenning EP, de Jong M, Henneman G. Free thyroxine assessed with three assays in sera of patients with nonthyroidal illness and of subjects with abnormal concentrations of thyroxine-binding proteins. Clin Chem 1993; 39: 1668–1674.PubMedGoogle Scholar
  150. 150.
    Brent GA, Hershman JM. Thyroxine therapy in patients with severe nonthyroidal illnesses and low serum thyroxine concentration. J Clin Endocrinol Metab 1986; 63: 1–8.PubMedGoogle Scholar
  151. 151.
    Faber J, Kirkegaard C, Rasmussen B, Westh H, Busch-Sorensen M, Jensen IW. Pituitary-thyroid axis in critical illness. J Clin Endocrinol Metab 1987; 65: 315–320.PubMedGoogle Scholar
  152. 152.
    Wong TK, Pekary AE, Soo-Hoo G, Bradley ME, Herschman JM. Comparison of methods for measuring free thyroxin in nonthyroidal illness. Clin Chem 1992; 38: 720–724.PubMedGoogle Scholar
  153. 153.
    DeGroot LJ, Mayor G. Admission screening by thyroid function tests in an acute general care teaching hospital. Am J Med 1992; 93: 558–564.Google Scholar
  154. 154.
    Kaplan MM. Nonthyroidal causes of abnormal thyroid function test data. J Clin Immunoassay 1989; 12: 90–99.Google Scholar
  155. 155.
    Franklyn JA, Black EG, Betteridge J, Sheppard MC. Comparison of second and third generation methods for measurement of serum thyrotropin in patients with overt hyperthyroidism, patients receiving thyroxine therapy, and those with nonthyroidal illness. J Clin Endocrinol Metab 1994; 78: 1368–1371.PubMedGoogle Scholar
  156. 156.
    Brent GA, Hershman JM, Braunstein GD. Patients with severe nonthyroidal illness and serum thyrotropin concentrations in the hypothyroid range. Am J Med 1986; 81: 463–466.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • Clark T. Sawin

There are no affiliations available

Personalised recommendations